🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.

Recruitingn/aAges 18 Years - 70 YearsFemaleJagiellonian University
NCT07295782 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Determination of fibrin clot properties along with thrombin generation in women after urigynecological surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18-70 * treatment failure (pharmacotherapy) due to uterine prolapse or urine incontinence Exclusion Criteria: * prolonged thromboprophylaxis * planned surgery other than due to urine incontinence/uterine prolapse * acquired or congenital thrombophilia
💊

What it tests

  • determination of fibrin clot properties
📍

Where

1 site
Gynecological Endocrinology Department
Krakow, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy